Who Is Patrick Soon-Shiong? Age, Biography, and Wiki
Patrick Soon-Shiong, born on July 29, 1952, is a prominent South African-American physician, surgeon, and entrepreneur with a groundbreaking impact on medicine and biotechnology. Known for his innovations and contributions to cancer treatment, he is celebrated not only for his medical prowess but also for his business acumen. As of 2025, he is 73 years old and continues to influence the medical landscape with his visionary ideas.
| Occupation | Billionaire |
|---|---|
| Date of Birth | July 29, 1952 |
| Age | 72 Years |
| Birth Place | Port Elizabeth, Union of South Africa |
| Horoscope | Leo |
| Country | South Africa |
Popularity
Patrick Soon-Shiong's Popularity over time
Height, Weight & Measurements
Patrick stands at an impressive height of 6 feet (183 cm), contributing to his commanding presence in both medical and business settings. His weight is approximately 180 lbs (82 kg). While specific body measurements are not publicly available, he embodies a professional and well-groomed appearance befitting his status in the health and business communities.
Family, Dating & Relationship Status
Patrick Soon-Shiong is married to Dr. Aileen Soon-Shiong, with whom he shares a deep familial bond and partnership in various health initiatives. Together, they have two children. As a private individual, Patrick tends to keep details about his personal life, including relationship status, away from the media spotlight, focusing instead on his professional endeavors and philanthropic work.
In 2017, Soon-Shiong and his wife were invited by the Smithsonian to be part of the permanent exhibit "Many Voices, One Nation" in the National Museum of American History in Washington DC.
Net Worth and Salary
As of 2025, Patrick Soon-Shiong has amassed an estimated net worth of over $7 billion, making him one of the wealthiest individuals in the healthcare sector. His wealth stems from a combination of successful business ventures, including the founding and sale of pharmaceutical companies and extensive investments in biotechnology. His strategies have greatly shaped the financial landscape of modern medicine.
Soon-Shiong's net worth is US$11.3 billion as of 2025 according to Bloomberg Billionaires Index. He has been called the richest man in Los Angeles and one of the wealthiest doctors in the world.
Career, Business and Investments
Patrick Soon-Shiong's career is marked by a series of impressive achievements. After earning his medical degree, he pioneered treatments and therapies for diabetes and cancer. He is the founder of NantWorks, a network of healthcare companies, and has significantly impacted personalized medicine. His entrepreneurial spirit is evident in his numerous investments in innovative startups, continuing to push the boundaries of science and technology.
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, and transplant surgeon. He is the inventor of the drug Abraxane, which is used for lung, breast, and pancreatic cancer.
Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College.
Social Network
Patrick is known for maintaining a relatively low profile on social media compared to other celebrities. However, he does have a presence on professional platforms like LinkedIn, where he shares insights about healthcare innovations and projects. His influence extends through various health-related conferences and forums, where he is an outspoken advocate for medical advancements.
Soon-Shiong founded NantHealth in 2007 to provide fiber-optic, cloud-based data infrastructure to share healthcare information.
Soon-Shiong went on to found NantWorks in September 2011, whose mission was "to converge ultra-low power semiconductor technology, supercomputing, high performance, secure advanced networks and augmented intelligence to transform how we work, play, and live." It owns a number of technology companies in the fields of healthcare, commerce, digital en
tertainment as well as a venture capital firm in the healthcare, education, science, and technology sectors.
Particular technologies include machine vision, object and voice recognition, low power semiconductors, supercomputing, and networking technologies. In January 2013, he founded another biotech company, NantOmics, to develop cancer drugs based on protein kinase inhibitors. NantOmics and its sister company, NantHealth, were subsidiaries of NantWorks.
Education
Patrick Soon-Shiong's educational background is as impressive as his career. He attended the University of Alberta for his undergraduate studies before pursuing a medical degree at the University of California, Los Angeles (UCLA). His extensive education and training laid the foundation for his future success in the medical and business fields.
He immigrated to the United States and began surgical training at University of California, Los Angeles (UCLA), and became a board-certified surgeon in 1984. Soon-Shiong is a Fellow of the Royal College of Surgeons (Canada) and a Fellow of the American College of Surgeons. He was granted United States citizenship.
